3,4-dihydroxyphenylacetic acid has been researched along with triadimefon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cory-Slechta, DA; Reeves, R; Thiruchelvam, M | 1 |
| Gagnaire, F; Micillino, JC | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and triadimefon
| Article | Year |
|---|---|
Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Corpus Striatum; Drug Administration Schedule; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Neuronal Plasticity; Piperazines; Quinoxalines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Substance Withdrawal Syndrome; Time Factors; Triazoles | 2004 |
Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Chromatography, High Pressure Liquid; Dialysis Solutions; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Fluid; Fungicides, Industrial; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Male; Microdialysis; Neostriatum; Piperazines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Stereotyped Behavior; Tetrodotoxin; Time Factors; Triazoles | 2006 |